Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Van der Eecken

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
BMC Medical Genomics|July 8, 2020
Comparative analysis of somatic variant calling on matched FF and FFPE WGS samplesLouise de Schaetzen van Brienen, Maarten Larmuseau, Kim Van der Eecken, et al.
Cancer Treatment Reviews|January 27, 2019
Oligometastatic prostate cancer: The game is afootAndrea Lancia, Thomas Zilli, Verane Achard, et al.
World Journal of Urology|December 23, 2018
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime timeBert Dhondt, Elise De Bleser, Tom Claeys, et al.
Genome Medicine|April 23, 2020
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinomaLennart Raman, Malaïka Van der Linden, Kim Van der Eecken, et al.
Cancer Research|June 23, 2023
Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate CancerMarija Pizurica, Maarten Larmuseau, Kim Van der Eecken, et al.
European Urology Oncology|November 21, 2021
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic ReviewKim Van der Eecken, Jan Vanwelkenhuyzen, Matthew P Deek, et al.
European Urology|January 23, 2019
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial CarcinomaNora Sundahl, Gillian Vandekerkhove, Karel Decaestecker, et al.
JCO Precision Oncology|May 4, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate CancerNicolette M Fonseca, Kim Van der Eecken, Cameron Herberts, et al.
Virchows Archiv : an International Journal of Pathology|January 16, 2022
Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven studyKim Van der Eecken, Malaïka Van der Linden, Lennart Raman, et al.
The Prostate|June 3, 2022
Genomic biomarkers to guide precision radiotherapy in prostate cancerPhilip Sutera, Matthew P Deek, Kim Van der Eecken, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
BMC Medical Genomics|July 8, 2020
Comparative analysis of somatic variant calling on matched FF and FFPE WGS samplesLouise de Schaetzen van Brienen, Maarten Larmuseau, Kim Van der Eecken, et al.
Cancer Treatment Reviews|January 27, 2019
Oligometastatic prostate cancer: The game is afootAndrea Lancia, Thomas Zilli, Verane Achard, et al.
World Journal of Urology|December 23, 2018
Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer: not ready for prime timeBert Dhondt, Elise De Bleser, Tom Claeys, et al.
Genome Medicine|April 23, 2020
Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinomaLennart Raman, Malaïka Van der Linden, Kim Van der Eecken, et al.
Cancer Research|June 23, 2023
Whole Slide Imaging-Based Prediction of TP53 Mutations Identifies an Aggressive Disease Phenotype in Prostate CancerMarija Pizurica, Maarten Larmuseau, Kim Van der Eecken, et al.
European Urology Oncology|November 21, 2021
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic ReviewKim Van der Eecken, Jan Vanwelkenhuyzen, Matthew P Deek, et al.
European Urology|January 23, 2019
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial CarcinomaNora Sundahl, Gillian Vandekerkhove, Karel Decaestecker, et al.
JCO Precision Oncology|May 4, 2022
Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate CancerNicolette M Fonseca, Kim Van der Eecken, Cameron Herberts, et al.
Virchows Archiv : an International Journal of Pathology|January 16, 2022
Shallow whole-genome sequencing: a useful, easy to apply molecular technique for CNA detection on FFPE tumor tissue-a glioma-driven studyKim Van der Eecken, Malaïka Van der Linden, Lennart Raman, et al.
The Prostate|June 3, 2022
Genomic biomarkers to guide precision radiotherapy in prostate cancerPhilip Sutera, Matthew P Deek, Kim Van der Eecken, et al.
Pageof 3